Home › Funds › PSP Research LLC › EWTX
PSP Research LLC position in EWTX
EDGEWISE THERAPEUTICS INC · Health Care
PSP Research LLC reported holding 5,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$203K, representing 0.14% of its reported portfolio and ranking #37 among its reported holdings. PSP Research LLC has disclosed EWTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How PSP Research LLC's EWTX position evolved
PSP Research LLC first disclosed a stake in EWTX in Q1 2026 at 6,500 shares (US$205K). Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,000 shares valued at US$203K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 6.50K | $204.75K | New |
| Q2 2026 | 5.00K | $203.15K | Reduce |
| Q3 2026 | 5.00K | $203.00K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EWTX and 13F data
EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.5M), Paradigm Biocapital Advisors LP (US$415.1M), RA CAPITAL MANAGEMENT, L.P. (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EWTX
- ORBIMED ADVISORS LLC 15.52M sh · $630.52M · Q2 2026
- Paradigm Biocapital Advisors LP 10.22M sh · $415.05M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 8.39M sh · $341.00M · Q2 2026
- Novo Holdings A/S 5.35M sh · $217.37M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 4.73M sh · $192.12M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.37M sh · $177.71M · Q2 2026
- BAKER BROS. ADVISORS LP 3.70M sh · $150.40M · Q2 2026
- Siren, L.L.C. 3.18M sh · $129.39M · Q2 2026
- Cormorant Asset Management, LP 2.51M sh · $101.98M · Q2 2026
- Integral Health Asset Management, LLC 2.00M sh · $81.26M · Q2 2026
- BRAIDWELL LP 2.00M sh · $81.14M · Q2 2026
- MPM BioImpact LLC 1.62M sh · $65.85M · Q2 2026
More on PSP Research LLC
FAQ
How long has PSP Research LLC held EWTX?
PSP Research LLC has disclosed EWTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is PSP Research LLC's current position in EWTX?
As of Q3 2026, PSP Research LLC holds 5.00K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $203.00K, representing 0.14% of its reported portfolio and ranking #37.
Has PSP Research LLC been buying or selling EWTX?
In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in EWTX.
Which other funds hold EWTX?
Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.